Open | - |
Close | - |
Volume / Avg. | 62.000 / 257.710K |
Day Range | - - - |
52 Wk Range | 1.235 - 10.200 |
Market Cap | $56.576M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 33 |
Short Interest | 4.52% |
Days to Cover | 5.09 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Leap Therapeutics (NASDAQ: LPTX) through any online brokerage.
Other companies in Leap Therapeutics’s space includes: Kezar Life Sciences (NASDAQ:KZR), Curis (NASDAQ:CRIS), Elicio Therapeutics (NASDAQ:ELTX), CollPlant Biotechnologies (NASDAQ:CLGN) and vTv Therapeutics (NASDAQ:VTVT).
The latest price target for Leap Therapeutics (NASDAQ: LPTX) was reported by Baird on Tuesday, March 19, 2024. The analyst firm set a price target for 9.00 expecting LPTX to rise to within 12 months (a possible 307.24% upside). 12 analyst firms have reported ratings in the last year.
The stock price for Leap Therapeutics (NASDAQ: LPTX) is $2.21 last updated March 18, 2024 at 9:11 AM EDT.
There are no upcoming dividends for Leap Therapeutics.
Leap Therapeutics’s Q1 earnings are confirmed for Monday, May 13, 2024.
There is no upcoming split for Leap Therapeutics.
Leap Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.